share_log

鲁抗医药(600789.SH):氟哌啶醇注射液通过仿制药一致性评价

Shandong Lukang Pharmaceutical (600789.SH): Flupentixol Injection passed the generic drug consistency evaluation

Gelonghui Finance ·  Nov 5, 2024 16:04

Gelonghui November 5th | shandong lukang pharmaceutical (600789.SH) announced that its holding subsidiary shandong lukang pharmaceutical group site limited liability company has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for the consistency evaluation of the generic drug quality and efficacy of fluoropromethol injection. Fluoropromethol is a butyrophenone antipsychotic drug, which exerts its antipsychotic effect by blocking dopamine receptors in the brain and promoting the conversion of dopamine in the brain. It has a good effect in anti-delusion, anti-delirium, and anti-excitatory agitation, with a strong inhibitory effect on the dopaminergic action of the extrapyramidal system and a strong antiemetic effect.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment